Your browser doesn't support javascript.
loading
GLI1/GLI2 functional interplay is required to control Hedgehog/GLI targets gene expression.
Tolosa, Ezequiel J; Fernandez-Barrena, Maite G; Iguchi, Eriko; McCleary-Wheeler, Angela L; Carr, Ryan M; Almada, Luciana L; Flores, Luis F; Vera, Renzo E; Alfonse, Germine W; Marks, David L; Hogenson, Tara L; Vrabel, Anne M; Horn, Isaac P; Koenig, Amanda N; Safgren, Stephanie L; Sigafoos, Ashley N; Erkan, Mert; Romecin-Duran, Paola A; Sarabia Gonzalez, Alejandro; Zhou, Bo; Javelaud, Delphine; Marsaud, Veronique; Graham, Rondell P; Mauviel, Alain; Elsawa, Sherine F; Fernandez-Zapico, Martin E.
Afiliação
  • Tolosa EJ; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
  • Fernandez-Barrena MG; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
  • Iguchi E; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
  • McCleary-Wheeler AL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
  • Carr RM; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
  • Almada LL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
  • Flores LF; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
  • Vera RE; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
  • Alfonse GW; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
  • Marks DL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
  • Hogenson TL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
  • Vrabel AM; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
  • Horn IP; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
  • Koenig AN; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
  • Safgren SL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
  • Sigafoos AN; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
  • Erkan M; Department of Surgery, Koc University School of Medicine, Istanbul, Turkey.
  • Romecin-Duran PA; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
  • Sarabia Gonzalez A; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
  • Zhou B; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
  • Javelaud D; Institut Curie, PSL Research University, INSERM U1021, CNRS UMR3347, Team 'TGF-ß and Oncogenesis', Equipe Labellisée LIGUE 2016, F-91400, Orsay, France.
  • Marsaud V; Université Paris-Sud, F-91400, Orsay, France.
  • Graham RP; Institut Curie, PSL Research University, INSERM U1021, CNRS UMR3347, Team 'TGF-ß and Oncogenesis', Equipe Labellisée LIGUE 2016, F-91400, Orsay, France.
  • Mauviel A; Université Paris-Sud, F-91400, Orsay, France.
  • Elsawa SF; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, U.S.A.
  • Fernandez-Zapico ME; Institut Curie, PSL Research University, INSERM U1021, CNRS UMR3347, Team 'TGF-ß and Oncogenesis', Equipe Labellisée LIGUE 2016, F-91400, Orsay, France.
Biochem J ; 477(17): 3131-3145, 2020 09 18.
Article em En | MEDLINE | ID: mdl-32766732

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Rabdomiossarcoma / Proteínas Nucleares / Regulação Neoplásica da Expressão Gênica / Proteínas Hedgehog / Proteína GLI1 em Dedos de Zinco / Proteína Gli2 com Dedos de Zinco Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Rabdomiossarcoma / Proteínas Nucleares / Regulação Neoplásica da Expressão Gênica / Proteínas Hedgehog / Proteína GLI1 em Dedos de Zinco / Proteína Gli2 com Dedos de Zinco Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article